Radiology in COVID-19: What We Know Now and What Remains Unknown?
Radiology in COVID-19: The Known & the Unknowns
Infection with SARS-CoV-2 ranges from an asymptomatic condition to a severe and sometimes fatal disease, with mortality most frequently being the result of acute lung injury. The role of imaging has evolved during the pandemic, with CT initially being an alternative and possibly superior testing method compared with reverse transcriptase–polymerase chain reaction (RT-PCR) testing and evolving to having a more limited role based on specific indications. Several classification and reporting schemes were developed for chest imaging early during the pandemic for patients suspected of having COVID-19 to aid in triage when the availability of RT-PCR testing was limited and its level of performance was unclear. In this video, panelists talk about the pathophysiology in COVID-19 and CT Signs of COVID-19 including traction bronchiectasis.
This video is a part of the JBCPL body of knowledge conclave 2021. check out the entire conclave at https://medicaldialogues.in/JBCPL-BOK
Dr. Ashok K. Rajput
MBBS, DTCD, MD, DNB Chief Consultant Head (Department of Pulmonology)
Dr. Arun C Kotaru
MBBS, MD, DNB (Resp Med)